Dr. Ana Frӧbe is currently a clinical oncologist at the Department of Oncology and Nuclear Medicine of the University Hospital Centre Sestre Milosrdnice in Zagreb, Croatia, where she has been working since 1997 and heading the Brachytherapy Division since 2002.

Born in 1962 in Zagreb, she studied medicine and obtained post-graduate training for specialisation in Zagreb. From 1991 to 1997 she served as research assistant at the Research Institute Ruđer Bošković, where she obtained her MSc degree in 1994 and PhD degree in 2006.

Dr. Fröbe gained two post-doctoral studies in experimental pharmacology and oncology and completed her professional training in several world-renowned centres of excellence in cancer treatment, such as the National Cancer Institute in Tokyo, Japan (1997), Allgemeines Krankenhaus in Vienna, Austria (1998), the MD Anderson Cancer Center in Houston, Texas, USA (2001), the Mount Vernon Cancer Center, London, UK (2010), the Gasthuisberg University Hospital in Leuven, Belgium (2012).

She also attended teaching courses in oncology, radiotherapy and brachytherapy, in collaboration with the European Society for Therapeutic Radiology and Oncology (ESTRO).

She is currently Professor of Oncology at the Medical School and School of Dental Medicine of the University of Zagreb.

Dr. Fröbe has published several articles and book contributions in her field, and she is a co-author and editor of Oncology for Dental Medicine.

At present, she is involved in six international clinical phase III and IV studies (radiotherapy and chemotherapy in lung, oesophagus and rectal cancer, immunotherapy and chemotherapy in prostate cancer).

She is a member of ESMO and ESTRO, as well as of national medical societies, such as the Croatian Medical Association and the Austrian Society of Oncology and Radiotherapy ÖGRO.